vs

Side-by-side financial comparison of BADGER METER INC (BMI) and Dolby Laboratories, Inc. (DLB). Click either name above to swap in a different company.

Dolby Laboratories, Inc. is the larger business by last-quarter revenue ($395.6M vs $234.1M, roughly 1.7× BADGER METER INC). Dolby Laboratories, Inc. runs the higher net margin — 24.0% vs 14.3%, a 9.7% gap on every dollar of revenue. On growth, BADGER METER INC posted the faster year-over-year revenue change (14.1% vs 7.1%). Over the past eight quarters, Dolby Laboratories, Inc.'s revenue compounded faster (13.9% CAGR vs 9.2%).

Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.

Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.

BMI vs DLB — Head-to-Head

Bigger by revenue
DLB
DLB
1.7× larger
DLB
$395.6M
$234.1M
BMI
Growing faster (revenue YoY)
BMI
BMI
+7.1% gap
BMI
14.1%
7.1%
DLB
Higher net margin
DLB
DLB
9.7% more per $
DLB
24.0%
14.3%
BMI
Faster 2-yr revenue CAGR
DLB
DLB
Annualised
DLB
13.9%
9.2%
BMI

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
BMI
BMI
DLB
DLB
Revenue
$234.1M
$395.6M
Net Profit
$33.6M
$94.9M
Gross Margin
39.7%
88.7%
Operating Margin
18.4%
28.5%
Net Margin
14.3%
24.0%
Revenue YoY
14.1%
7.1%
Net Profit YoY
9.3%
3.4%
EPS (diluted)
$1.13
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMI
BMI
DLB
DLB
Q2 26
$395.6M
Q1 26
$346.7M
Q4 25
$234.1M
$346.7M
Q3 25
$222.2M
$307.0M
Q2 25
$238.1M
$315.5M
Q1 25
$222.2M
$369.6M
Q4 24
$205.2M
$357.0M
Q3 24
$208.4M
$304.8M
Net Profit
BMI
BMI
DLB
DLB
Q2 26
$94.9M
Q1 26
$53.3M
Q4 25
$33.6M
$53.3M
Q3 25
$35.1M
$49.3M
Q2 25
$34.6M
$46.1M
Q1 25
$38.4M
$91.8M
Q4 24
$30.7M
$67.8M
Q3 24
$32.0M
$58.6M
Gross Margin
BMI
BMI
DLB
DLB
Q2 26
88.7%
Q1 26
87.5%
Q4 25
39.7%
87.5%
Q3 25
43.1%
87.1%
Q2 25
41.1%
86.1%
Q1 25
42.9%
90.3%
Q4 24
40.3%
88.6%
Q3 24
40.2%
88.8%
Operating Margin
BMI
BMI
DLB
DLB
Q2 26
28.5%
Q1 26
17.9%
Q4 25
18.4%
17.9%
Q3 25
20.7%
9.7%
Q2 25
18.8%
15.1%
Q1 25
22.2%
29.2%
Q4 24
19.1%
22.4%
Q3 24
19.5%
15.2%
Net Margin
BMI
BMI
DLB
DLB
Q2 26
24.0%
Q1 26
15.4%
Q4 25
14.3%
15.4%
Q3 25
15.8%
16.1%
Q2 25
14.5%
14.6%
Q1 25
17.3%
24.8%
Q4 24
15.0%
19.0%
Q3 24
15.4%
19.2%
EPS (diluted)
BMI
BMI
DLB
DLB
Q2 26
$0.99
Q1 26
$0.55
Q4 25
$1.13
$0.55
Q3 25
$1.19
$0.50
Q2 25
$1.17
$0.48
Q1 25
$1.30
$0.94
Q4 24
$1.04
$0.70
Q3 24
$1.08
$0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMI
BMI
DLB
DLB
Cash + ST InvestmentsLiquidity on hand
$594.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$713.3M
$2.6B
Total Assets
$973.6M
$3.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMI
BMI
DLB
DLB
Q2 26
$594.7M
Q1 26
$644.6M
Q4 25
$644.6M
Q3 25
$702.6M
Q2 25
$699.3M
Q1 25
$626.6M
Q4 24
$520.8M
Q3 24
$482.0M
Stockholders' Equity
BMI
BMI
DLB
DLB
Q2 26
$2.6B
Q1 26
$2.6B
Q4 25
$713.3M
$2.6B
Q3 25
$702.5M
$2.6B
Q2 25
$677.6M
$2.6B
Q1 25
$641.7M
$2.6B
Q4 24
$606.2M
$2.5B
Q3 24
$591.2M
$2.5B
Total Assets
BMI
BMI
DLB
DLB
Q2 26
$3.2B
Q1 26
$3.2B
Q4 25
$973.6M
$3.2B
Q3 25
$978.3M
$3.2B
Q2 25
$936.4M
$3.2B
Q1 25
$899.6M
$3.2B
Q4 24
$816.4M
$3.2B
Q3 24
$802.9M
$3.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMI
BMI
DLB
DLB
Operating Cash FlowLast quarter
$54.8M
$147.3M
Free Cash FlowOCF − Capex
$50.8M
FCF MarginFCF / Revenue
21.7%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
1.63×
1.55×
TTM Free Cash FlowTrailing 4 quarters
$169.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMI
BMI
DLB
DLB
Q2 26
$147.3M
Q1 26
$54.8M
Q4 25
$54.8M
$54.8M
Q3 25
$51.3M
$472.2M
Q2 25
$44.6M
$67.7M
Q1 25
$33.0M
$174.9M
Q4 24
$52.1M
$106.8M
Q3 24
$45.1M
$327.3M
Free Cash Flow
BMI
BMI
DLB
DLB
Q2 26
Q1 26
Q4 25
$50.8M
$50.2M
Q3 25
$48.2M
$435.9M
Q2 25
$40.6M
$61.3M
Q1 25
$30.1M
$168.0M
Q4 24
$47.4M
$100.0M
Q3 24
$42.0M
$297.2M
FCF Margin
BMI
BMI
DLB
DLB
Q2 26
Q1 26
Q4 25
21.7%
14.5%
Q3 25
21.7%
142.0%
Q2 25
17.1%
19.4%
Q1 25
13.5%
45.5%
Q4 24
23.1%
28.0%
Q3 24
20.1%
97.5%
Capex Intensity
BMI
BMI
DLB
DLB
Q2 26
Q1 26
Q4 25
1.7%
1.3%
Q3 25
1.4%
11.8%
Q2 25
1.7%
2.0%
Q1 25
1.3%
1.9%
Q4 24
2.3%
1.9%
Q3 24
1.5%
9.8%
Cash Conversion
BMI
BMI
DLB
DLB
Q2 26
1.55×
Q1 26
1.03×
Q4 25
1.63×
1.03×
Q3 25
1.46×
9.57×
Q2 25
1.29×
1.47×
Q1 25
0.86×
1.91×
Q4 24
1.70×
1.57×
Q3 24
1.41×
5.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMI
BMI

Transferred At Point In Time$198.6M85%
Transferred Over Time$22.1M9%
Other$13.4M6%

DLB
DLB

Licensing$372.2M94%
Products and services$23.4M6%

Related Comparisons